Atlas Trials

Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy

Clinical trial NCT02628106 · COMPLETED

Trial details

NCT number
NCT02628106
Sponsor
West China Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Diabetic Nephropathy
Start date
2015-12-01
Primary completion
2016-01-01
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.